HRS-1893 - Jiangsu Hengrui Pharma
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Mar 5, 2025 - P2 | N=84 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting 
Enrollment open • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT06816251
 
Mar 5, 2025
 
Prev Next